Check-Cap Ltd. (MBAI) - Total Liabilities
Based on the latest financial reports, Check-Cap Ltd. (MBAI) has total liabilities worth $4.05 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Check-Cap Ltd. (MBAI) net asset momentum to track the company's year-over-year net asset growth rate.
Check-Cap Ltd. - Total Liabilities Trend (2021–2025)
This chart illustrates how Check-Cap Ltd.'s total liabilities have evolved over time, based on quarterly financial data.
Check-Cap Ltd. Competitors by Total Liabilities
The table below lists competitors of Check-Cap Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Golden Pursuit Resources Ltd
V:GDP
|
Canada | CA$862.22K |
|
Visgeneer
TWO:4197
|
Taiwan | NT$135.94 Million |
|
Kim Hin Joo
KLSE:0210
|
Malaysia | RM23.55 Million |
|
Eros International Media Limited
NSE:EROSMEDIA
|
India | Rs10.25 Billion |
|
EA Holdings Bhd
KLSE:0154
|
Malaysia | RM5.99 Million |
|
Scandinavian ChemoTech AB Series B
ST:CMOTEC-B
|
Sweden | Skr9.47 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Check-Cap Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Check-Cap Ltd..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Check-Cap Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Check-Cap Ltd. (2021–2025)
The table below shows the annual total liabilities of Check-Cap Ltd. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $4.05 Million | +121.62% |
| 2024-12-31 | $1.83 Million | +37.37% |
| 2023-12-31 | $1.33 Million | -67.79% |
| 2022-12-31 | $4.13 Million | -16.89% |
| 2021-12-31 | $4.97 Million | -- |
About Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.